Browsing Tag

#renaldisease

Unicycive Reports Key Findings of UNI-494 Efficacy in Preclinical Animal Model of…

Eli Pacheco Sep 7, 2022 0

Established animal model of AKI showed a statistically significant reduction of a key biomarker of kidney injury when treated with UNI-494 AKI remains a serious unmet medical need with no…

Health

Unicycive Announces Multiple Abstracts Selected for Presentation at American Society…

Eli Pacheco Aug 24, 2022 0

LOS ALTOS, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney…

Health

Unicycive Reports Key Findings from Market Research with Nephrologists

Eli Pacheco Jul 20, 2022 0

Renazorb product profile rated as best-in-class phosphate binder Nephrologists report high prescribing intent for Renazorb pending FDA approval LOS ALTOS, Calif., July 20, 2022…